Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8402 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8393 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8383 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8284 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8269 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8121 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8103 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8061 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD7228 |
Approved |
0.805 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7988 |
Intermediate Similarity |
NPD37 |
Approved |
0.7977 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7952 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7952 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7939 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7886 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7886 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7727 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7719 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD5403 |
Approved |
0.767 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7667 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD6799 |
Approved |
0.76 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7595 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7558 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7545 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7515 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7452 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.744 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7409 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7409 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7399 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7277 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD1091 |
Approved |
0.725 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD919 |
Approved |
0.724 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.724 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7204 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7182 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7182 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7179 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD2796 |
Approved |
0.707 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7066 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7066 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7044 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7025 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7012 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD6273 |
Approved |
0.699 |
Remote Similarity |
NPD7584 |
Approved |
0.6989 |
Remote Similarity |
NPD3749 |
Approved |
0.6988 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6981 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6976 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD5353 |
Approved |
0.697 |
Remote Similarity |
NPD6032 |
Approved |
0.6966 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6963 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD1203 |
Approved |
0.6957 |
Remote Similarity |
NPD3268 |
Approved |
0.6954 |
Remote Similarity |
NPD7585 |
Approved |
0.6948 |
Remote Similarity |
NPD1357 |
Approved |
0.6946 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD1535 |
Discovery |
0.6919 |
Remote Similarity |
NPD3686 |
Approved |
0.6919 |
Remote Similarity |
NPD3687 |
Approved |
0.6914 |
Remote Similarity |
NPD7972 |
Discontinued |
0.6909 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6904 |
Remote Similarity |
NPD7583 |
Approved |
0.6903 |
Remote Similarity |
NPD17 |
Approved |
0.6901 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6901
|
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |